MedTrace Logo

Evaluation of the Efficacy and Safety of Zinc in Viral Infections

NCT05212480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2023-03-16

No results posted yet for this study

Summary

The main objective of the clinical study is to evaluate the efficacy of Zinc supplementation in non-critically ill Covid-19 patients..

Conditions

  • SARS-CoV2 Infection

Interventions

DIETARY_SUPPLEMENT

Zinc

For each patient included, a prescription regimen of zinc (in bisglycinate form) is proposed at a dose of 25 mgtwice a day for 15 days for the intervention arm. This dose of zinc is to be taken away from meals.

DIETARY_SUPPLEMENT

Placebo

For each patient included, a prescription of an identical to the intervention arm concerning shape, smell, taste and color pill of placebo . This dose of zinc is to be taken away from meals.

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • Nouira A semir, Pr · emergency department of Fattouma Bourguiba Monastir

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2022-05-04
Completion
2022-05-04

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05212480 on ClinicalTrials.gov